Bill
S 4194
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
2026-2027 Regular Session
Introduced by Vin Gopal and 2 co-sponsors
Allows prescribing Schedule II controlled substances via telemedicine without in-person exam, with safety, documentation, and oversight requirements.
Reported from Senate Committee as a Substitute, 2nd Reading